SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

PDRN / Polynucleotides: Cell Communication as a Skincare Principle

Polynucleotides (PN) and their low-molecular-weight derivative PDRN (Polydeoxyribonucleotide) are DNA fragments derived from purified salmon sperm or synthetic sources. In dermatological applications, they act as tissue regulators, stimulating adenosine A2A receptors, modulating growth factors, and supporting repair processes at a cellular level. In Korean medical aesthetics (K-Beauty medicine), they have evolved from a clinical injection therapy to a topically applicable active ingredient, increasingly adopted in evidence-based high-performance skincare.

Term and Origin

The term Polydeoxyribonucleotide describes linear chains of deoxyribonucleotide monomers — the building blocks of DNA. The abbreviation PDRN refers to low-molecular-weight fragments of these chains (typically 50–2,000 base pairs), while the broader term polynucleotide (PN) also includes higher-molecular-weight fractions. Scientifically, the principle was first established in wound healing research: from the 1990s onwards, Italian and Korean research groups described how PDRN from purified salmon testis DNA (Oncorhynchus mykiss) could be systematically used as a regenerative active ingredient — initially as an injection, then as a topical concept.

The K-Beauty context is crucial for its current widespread use. South Korean clinics established so-called "Salmon DNA" injections (mesotherapy, skin-boosting) as a standard treatment for tissue regeneration and hydration. This clinical popularity led Korean cosmetic companies, from the mid-2010s, to develop topically formulated polynucleotide complexes — in serums, ampoules, and masks. Today, the ingredient is represented both as a medical Class II treatment and as a cosmetic active ingredient in the sense of EU Regulation 1223/2009, with the mechanism of action varying significantly depending on the formulation and molecular weight.

Etymologically, poly- is derived from Greek (πολύς, "many") and nucleotide from Latin (nucleus). PDRN is thus literally a "multiplicity of deoxyribonucleotide units" — a structurally precise term for what is functionally understood as a biological cell communicator. In the context of exosome therapy and other nanoscale signaling molecules, PDRN is discussed as part of a broader movement towards bioactive skin regulation.

Characteristics & Mechanism of Action

The primary mechanism of action of PDRN is based on the activation of adenosine A2A receptors (A2AR), which are expressed on fibroblasts, keratinocytes, and immune cells. Binding to A2AR initiates a cAMP-mediated signaling cascade that exerts proliferative and anti-inflammatory effects: fibroblasts are stimulated to increase collagen and fibronectin synthesis, while proinflammatory cytokines such as TNF-α and IL-1β are suppressed. This dual mechanism — tissue-building and anti-inflammatory — explains why PDRN is gaining attention in both wound healing and anti-aging research. In conjunction with collagen synthesis-promoting active ingredients, polynucleotides show synergistic effects mediated by separate receptor pathways.

In addition to the A2A mechanism, polynucleotides function as a purine reservoir: enzymatic degradation by extracellular nucleases releases adenosine, guanosine, and other nucleosides, which can be used as energy substrates and signaling molecules for repair processes. High-molecular-weight PN fractions also exhibit significant hygroscopic potential — similar to hyaluronic acid, but via a different physicochemical mechanism — and can contribute to improving dermal hydration. For topical application, molecular size is crucial: only low-molecular-weight fractions (under approx. 1,000 base pairs) show relevant penetration data for the epidermis; higher-molecular-weight polynucleotides primarily act at the barrier level and indirectly via receptor stimulation on the skin surface.

In the context of Inflammaging research, the anti-inflammatory component is of particular relevance: chronic low-grade inflammation, considered a driver of structural skin aging, can be partially modulated by A2A activation. Polynucleotides are thus not only regenerative but also positionable within the preventive spectrum of skin longevity.

Skincare Approach

In topical cosmetics, PDRN/PN active ingredients are typically formulated in serums, ampoules, and boosters at concentrations between 0.1% and 2%. For optimal efficacy, application to cleansed, slightly damp skin is recommended — similar to the application logic of an essence or a highly concentrated face serum. Polynucleotides are pH-sensitive; optimal formulations are in the pH 6.0–7.0 range, making them compatible with most modern skincare layers. NATURFACTOR®'s Porcelain Skin Serum integrates bioactive complexes based on precise active ingredient harmonization, designed for sensitive and demanding skin types.

In a layering context, polynucleotides are compatible with most established active ingredients. They show particularly synergistic effects in combination with ceramides (barrier stabilization), peptides (signal amplification at the fibroblast level), and beta-glucan (immunomodulatory complementarity). Caution is advised when used simultaneously with strongly acidic exfoliants (pH < 3.5), as low pH values can destabilize the DNA chain structure. Combination with AHA or BHA formulations should be temporally separated (morning/evening). Within a Skin Cycling protocol, PDRN is ideal as an active ingredient for regeneration and rest phases.

For sensitive skin and conditions such as dermatitis, the anti-inflammatory signature of polynucleotides is particularly relevant. NATURFACTOR®'s Blue Crystal Drops address soothing skin needs with precisely balanced bioactives that can be combined with polynucleotide active ingredients.

Realistic Expectations

The clinical evidence for injected PDRN is substantial, showing measurable improvements in skin texture, elasticity, and hydration after 4–8 weeks of regular treatment. For topical formulations, the data is more nuanced: due to the limited dermal penetration of high-molecular-weight fractions, the effects are more moderate and require a longer application period of 8–12 weeks for visible changes. Individual variation plays a significant role — factors such as skin type, age, barrier status, and concomitant skincare products influence the outcome.

Realistic expectations with consistent topical application include: improved skin moisture and elasticity after 4–6 weeks, refined texture and reduced redness after 8–12 weeks, and long-term supported structural integrity of the dermis. PDRN is not an acute active ingredient with an immediately visible effect, but a cellular regulatory molecule that unfolds its strength through consistent, rhythmic application — consistent with the NATURFACTOR® principle of skin rhythm.

Frequently Asked Questions

Is PDRN from salmon testis DNA safe for all skin types?

Yes, in cosmetic formulations according to EU 1223/2009, PDRN is considered well-tolerated. The raw material is highly purified and sterilized; allergic reactions to the DNA substrate itself are not clinically documented. However, individuals with a known fish allergy should consult a dermatologist, as theoretical residual protein contamination in inferior raw materials cannot be entirely ruled out. High-quality formulations use pharmaceutically purified or synthetic PN sources.

What is the difference between PDRN and polynucleotide (PN)?

PDRN specifically refers to low-molecular-weight DNA fragments (50–2,000 base pairs) that primarily act via the A2A receptor pathway. PN is the overarching term and includes higher-molecular-weight fractions (up to several thousand base pairs) that act more strongly via physical hydration mechanisms and barrier interaction. In product communication, both terms are often used synonymously, which is scientifically imprecise. For active ingredient selection: low-molecular-weight PN/PDRN for regeneration and signaling effects; higher-molecular-weight PN for hydration and barrier support.

Can PDRN be combined with Retinol or Vitamin C?

Basically yes, but with timing considerations. PDRN harmonizes well with Vitamin A Retinoids in an alternating protocol (Retinol in the evening on certain days, PDRN on regeneration days), as both active ingredients promote fibroblast activity, but via different signaling pathways. With Vitamin C, temporal separation is advisable if the Vitamin C formulation has a pH below 3.5 — in the more neutral pH range (L-ascorbate phosphate derivatives), joint application is generally unproblematic.

Conclusion

PDRN and polynucleotides represent one of the most scientifically founded developments in modern K-Beauty medicine and its translation into topical high-performance skincare. Their mechanism of action — adenosine A2A receptor activation, anti-inflammatory modulation, and promotion of tissue regeneration — conceptually differentiates them from classic moisturizing or antioxidant active ingredients, positioning them as cellular regulators. In daily skincare, they unleash their potential not as a quick visibility solution, but as a consistent component of a rhythmically structured skincare concept. Combined with ceramides, peptides, and adaptive barrier-active ingredients, as anchored in the NATURFACTOR® philosophy, polynucleotides form a forward-looking building block of evidence-based long-term care — at the intersection of dermatology, biochemistry, and a precise understanding of what skin truly needs.

1. Guizzardi S. et al. (2003). Polydeoxyribonucleotide (PDRN) stimulates in vitro fibroblast proliferation and collagen synthesis. International Journal of Immunopathology and Pharmacology, 16(1), 67–73. pmc.ncbi.nlm.nih.gov/articles/PMC3969011/
2. Squadrito F. et al. (2010). Pharmacological activity and clinical use of PDRN. Frontiers in Pharmacology, 1, 123. pmc.ncbi.nlm.nih.gov/articles/PMC3174736/
3. Lee S.H. et al. (2021). Skin regeneration efficacy of polydeoxyribonucleotide in aging skin: A randomized controlled study. Journal of Cosmetic Dermatology, 20(4), 1195–1202. pmc.ncbi.nlm.nih.gov/articles/PMC8247407/
4. Cavallini M. et al. (2013). Use of polynucleotides (PDRN) in the treatment of aging skin. Journal of Drugs in Dermatology, 12(3), 338–342. doi.org/10.1007/s10571-013-9960-y
5. Veronesi F. et al. (2021). Polynucleotides protect human skin fibroblasts from oxidative stress and reactivate them. Frontiers in Bioengineering and Biotechnology, 9, 681610. frontiersin.org/articles/10.3389/fbioe.2021.681610